Thomsen Jillian B.
- SEC CIK
- 0001433457
No open-market purchases or sales filed in the past year.
Current role at each company
- NKTR Nektar TherapeuticsChief Financial Officeras of Feb 17, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Thomsen Jillian B. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 17, 2023 (view filing) | Feb 16 | 1 day | Thomsen Jillian B.Chief Financial Officer | SSale | −10.3K | $3.00 | −$30.8K | −3.2%313.5K after | |
| Nov 18, 2022 (view filing) | Nov 16 | 2 days | Thomsen Jillian B.Chief Financial Officer | SSale | −11.1K | $3.57 | −$39.6K | −3.3%323.8K after | |
| Aug 17, 2022 (view filing) | Aug 16 | 1 day | Thomsen Jillian B.SVP & Chief Accounting Officer | SSale | −2.01K | $4.76 | −$9.55K | −0.6%334.9K after | |
| May 17, 2022 (view filing) | May 16 | 1 day | Thomsen Jillian B.SVP & Chief Accounting Officer | SSale | −5.84K | $3.95 | −$23.1K | −3.3%170.4K after | |
| Feb 18, 2022 (view filing) | Feb 16 | 2 days | Thomsen Jillian B.SVP & Chief Accounting Officer | SSale | −2.36K | $10.95 | −$25.9K | −1.4%165.3K after | |
| Nov 17, 2021 (view filing) | Nov 16 | 1 day | Thomsen Jillian B.SVP & Chief Accounting Officer | SSale | −6.74K | $13.16 | −$88.7K | −4.4%146.0K after | |
| Aug 18, 2021 (view filing) | Aug 16 | 2 days | Thomsen Jillian B.SVP & Chief Accounting Officer | SSale | −13.3K | $13.83 | −$184.5K | −8.8%137.8K after |